Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U1 small nuclear 123, pseudogene (RNU1-123P) is a member of the U1 small nuclear RNA family, found in several locations in the human genome, and classified as a pseudogene because it has sequence similarity to the functional U1 snRNA gene but is typically non-coding and non-functional. Functional U1 snRNA is part of the spliceosome and critical for pre-mRNA splicing[3][4], but pseudogene members like RNU1-123P are not translated and generally lack critical sequences required for proper small nuclear ribonucleoprotein (snRNP) assembly and biological activity[1][2][4]. While some U1 snRNA pseudogenes have been found to produce variant snRNAs that may participate in gene regulation[4], there is no evidence that RNU1-123P encodes a functional RNA, is productively transcribed, or plays a direct role in disease networks or therapeutic mechanisms[1][2][4]. The classification as a pseudogene means its use as a therapeutic target or disease biomarker is unsupported.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U1 small nuclear 123, pseudogene (RNU1-123P).